Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-31 Purchase |
2025-04-02 4:37 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
16,497 | $12.83 | $211,736 | 1,068,701 (Indirect) |
View |
| 2025-03-26 Purchase |
2025-03-28 4:51 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
900,000 | $13 | $11,700,000 | 1,066,764 (Indirect) |
View |
| 2024-12-23 Purchase |
2024-12-26 4:28 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
47,520 | $11.09 | $527,174 | 960,554 (Indirect) |
View |
| 2024-12-03 Purchase |
2024-12-05 4:36 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
42,000 | $9.6 | $403,200 | 955,124 (Indirect) |
View |
| 2024-11-19 Purchase |
2024-11-21 4:24 pm |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
41,436 | $10.05 | $416,616 | 950,314 (Indirect) |
View |
| 2023-08-11 Purchase |
2023-08-14 5:13 pm |
Benitec Biopharma Inc. | BNTC | Boston Megan Executive Director |
25,907 | $0 | $0 | 51,834 (Indirect Direct) |
View |
| 2023-08-11 Purchase |
2023-08-14 5:10 pm |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
51,813 | $0 | $0 | 103,910 (Direct) |
View |
| 2021-04-28 Purchase |
2021-12-09 4:55 pm |
Benitec Biopharma Inc. | BNTC | Oliveira Steven Michael 10% Owner |
331,877 | $4.5121 | $1,497,454 | 1,000,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-12 Gift |
2025-03-13 4:43 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
103,626 | $0 | 103,910 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 2:20 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
51,813 | $3.86 | 103,910 (Direct) |
View |
| 2025-02-27 Exercise |
2025-03-03 2:20 pm |
2023-08-11 2028-08-11 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
51,813 | $0 | 103,910 (Direct) |
View |
Ownership |
2025-01-03 5:39 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | Mukadam Sophie Chief Operating Officer |
0 | $0 | 412,485 (Indirect) |
View |
| 2024-12-09 Option Award |
2024-12-11 6:48 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Mehta Kishan Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 5:24 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Francis Peter Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 5:22 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 5:20 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Smith Edward F Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 5:19 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Banks Jerel A. Chief Executive Officer |
2,310,000 | $0 | 2,310,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 5:17 pm |
N/A 2034-12-09 |
Benitec Biopharma Inc. | BNTC | Boston Megan Executive Director |
720,000 | $0 | 720,000 (Direct) |
View |
| 2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
1,368,180 | $0.0001 | 4,758,835 (Indirect) |
View |
| 2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
588,236 | $1.9299 | 4,758,835 (Indirect) |
View |
| 2024-09-26 Exercise |
2024-09-30 5:17 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
5,181,347 | $3.86 | 4,758,835 (Indirect) |
View |
| 2024-09-26 Exercise |
2024-09-30 5:17 pm |
2022-12-09 2027-12-09 |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Averill Madison Master Fund Ltd. Averill Master Fund Ltd. Cowen Aaron Director 10% Owner |
16,549,527 | $0 | 4,758,835 (Indirect) |
View |
Ownership |
2024-05-02 5:27 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | SUVRETTA CAPITAL MANAGEMENT LLC Cowen Aaron Averill Madison Master Fund Ltd. Averill Master Fund Ltd. 10% Owner |
0 | $0 | 15,233,011 (Indirect) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:13 pm |
N/A 2034-03-06 |
Benitec Biopharma Inc. | BNTC | Banks Jerel A. Chief Executive Officer |
466,554 | $0 | 466,554 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:12 pm |
N/A 2034-03-06 |
Benitec Biopharma Inc. | BNTC | Boston Megan Executive Director |
200,004 | $0 | 200,004 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-07 7:57 pm |
N/A 2033-12-06 |
Benitec Biopharma Inc. | BNTC | Smith Edward F Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-07 7:56 pm |
N/A 2033-12-06 |
Benitec Biopharma Inc. | BNTC | Francis Peter Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-07 7:55 pm |
N/A 2033-12-06 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:13 pm |
N/A 2033-06-13 |
Benitec Biopharma Inc. | BNTC | Boston Megan Executive Director |
153,000 | $0 | 153,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:11 pm |
N/A 2033-06-13 |
Benitec Biopharma Inc. | BNTC | Banks Jerel A. Chief Executive Officer |
356,900 | $0 | 356,900 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 7:22 pm |
N/A 2032-12-07 |
Benitec Biopharma Inc. | BNTC | Smith Edward F Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 7:22 pm |
N/A 2032-12-07 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 7:21 pm |
N/A 2032-12-07 |
Benitec Biopharma Inc. | BNTC | Francis Peter Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 6:56 pm |
N/A 2031-12-08 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 6:56 pm |
N/A 2031-12-08 |
Benitec Biopharma Inc. | BNTC | Smith Edward F Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 6:55 pm |
N/A 2031-12-08 |
Benitec Biopharma Inc. | BNTC | Francis Peter Director |
12,000 | $0 | 12,000 (Direct) |
View |
Ownership |
2021-12-09 4:53 pm |
N/A N/A |
Benitec Biopharma Inc. | BNTC | Oliveira Steven Michael 10% Owner |
0 | $0 | 668,123 (Indirect) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:59 pm |
N/A 2030-12-09 |
Benitec Biopharma Inc. | BNTC | BUCHI J KEVIN Director |
23,601 | $0 | 23,601 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:56 pm |
N/A 2030-12-09 |
Benitec Biopharma Inc. | BNTC | Francis Peter Director |
23,601 | $0 | 23,601 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:55 pm |
N/A 2030-12-09 |
Benitec Biopharma Inc. | BNTC | Smith Edward F Director |
23,601 | $0 | 23,601 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:53 pm |
N/A 2030-12-09 |
Benitec Biopharma Inc. | BNTC | Boston Megan Executive Director |
142,172 | $0 | 142,172 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:51 pm |
N/A 2030-12-09 |
Benitec Biopharma Inc. | BNTC | Banks Jerel A. Chief Executive Officer |
284,345 | $0 | 284,345 (Direct) |
View |